Prohibitin ligands in cell death and survival: Mode of action and therapeutic potential

Chemistry and Biology

Volumn 20, Issue 3, 2013, Pages 316-331

  Thuaud, Frédéric ^a   Ribeiro, Nigel ^a   Nebigil, Canan G ^a   Désaubry, Laurent ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOTIDE; AFTIN 4; ANTINEOPLASTIC AGENT; AURILIDE; CAPSAICIN; FLAVAGLINE; HERBACEOUS AGENT; HISTONE DEACETYLASE; LIGAND; MELANOGENIN; MESSENGER RNA; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROHIBITIN; PROTEIN 14 3 3; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN VP1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SMAD PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL CYCLE ARREST; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONFOCAL MICROSCOPY; CROSS LINKING; DEGENERATIVE DISEASE; DIABETES MELLITUS; ENDOTHELIUM CELL; ENTERITIS; EXTRACELLULAR SPACE; GENOMIC INSTABILITY; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INSULIN RESISTANCE; LIPID RAFT; LIPID STORAGE; METABOLIC DISORDER; MICROGLIA; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MYOBLAST; NUCLEAR EXPORT SIGNAL; OBESITY; OXIDATIVE STRESS; PALMITOYLATION; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROADIPOCYTE; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTO ONCOGENE; REPERFUSION INJURY; RESPIRATORY CHAIN; REVIEW; T LYMPHOCYTE ACTIVATION; ULTRAVIOLET C RADIATION;

ANIMALS; CELL DEATH; CELL SURVIVAL; DISEASE; DRUG DISCOVERY; HUMANS; LIGANDS; REPRESSOR PROTEINS;

EID: 84875439224     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2013.02.006     Document Type: Review

References (175)

1. L. Alinari, C.J. Prince, R.B. Edwards, W.H. Towns, R. Mani, A. Lehman, X. Zhang, D. Jarjoura, L. Pan, and A.D. Kinghorn Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol Clin. Cancer Res. 18 2012 4600 4611
2. S.R. Ande, and S. Mishra Prohibitin interacts with phosphatidylinositol 3,4,5-triphosphate (PIP3) and modulates insulin signaling Biochem. Biophys. Res. Commun. 390 2009 1023 1028
3. S.R. Ande, and S. Mishra Palmitoylation of prohibitin at cysteine 69 facilitates its membrane translocation and interaction with Eps 15 homology domain protein 2 (EHD2) Biochem. Cell Biol. 88 2010 553 558
4. S.R. Ande, Y. Gu, B.L.G. Nyomba, and S. Mishra Insulin induced phosphorylation of prohibitin at tyrosine114 recruits Shp1 Biochim. Biophys. Acta. 1793 2009 1372 1378
5. S.R. Ande, S. Moulik, and S. Mishra Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin: implication for a novel binary switch PLoS ONE 4 2009 e4586
6. S.R. Ande, Z. Xu, Y. Gu, and S. Mishra Prohibitin has an important role in adipocyte differentiation Int J Obes 36 2012 1236 1244
7. S. Bacher, G. Achatz, M.L. Schmitz, and M.C. Lamers Prohibitin and prohibitone are contained in high-molecular weight complexes and interact with α-actinin and annexin A2 Biochimie 84 2002 1207 1220
8. J.W. Back, M.A. Sanz, L. De Jong, L.J. De Koning, L.G.J. Nijtmans, C.G. De Koster, L.A. Grivell, H. Van Der Spek, and A.O. Muijsers A structure for the yeast prohibitin complex: Structure prediction and evidence from chemical crosslinking and mass spectrometry Protein Sci. 11 2002 2471 2478
9. K.F. Barnhart, D.R. Christianson, P.W. Hanley, W.H. Driessen, B.J. Bernacky, W.B. Baze, S. Wen, M. Tian, J. Ma, and M.G. Kolonin A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys Sci. Transl. Med. 3 2011 108ra112
10. B. Baumann, F. Bohnenstengel, D. Siegmund, H. Wajant, C. Weber, I. Herr, K.M. Debatin, P. Proksch, and T. Wirth Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells J. Biol. Chem. 277 2002 44791 44800
11. Y. Bernard, N. Ribeiro, F. Thuaud, G. Türkeri, R. Dirr, M. Boulberdaa, C.G. Nebigil, and L. Désaubry Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27 PLoS ONE 6 2011 e25302
12. H.-G. Bernstein, K.-H. Smalla, D. Dürrschmidt, G. Keilhoff, H. Dobrowolny, J. Steiner, A. Schmitt, M.R. Kreutz, and B. Bogerts Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease Neuromolecular Med. 14 2012 270 280
13. K. Bettayeb, N. Oumata, Y. Zhang, W. Luo, V. Bustos, H. Galons, P. Greengard, L. Meijer, and M. Flajolet Small-molecule inducers of Aβ-42 peptide production share a common mechanism of action FASEB J. 26 2012 5115 5123
14. M. Bleumink, R. Köhler, M. Giaisi, P. Proksch, P.H. Krammer, and M. Li-Weber Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression Cell Death Differ. 18 2011 362 370
15. K. Boengler, D. Hilfiker-Kleiner, G. Heusch, and R. Schulz Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion Basic Res. Cardiol. 105 2010 771 785
16. M.E. Bordeleau, F. Robert, B. Gerard, L. Lindqvist, S.M. Chen, H.G. Wendel, B. Brem, H. Greger, S.W. Lowe, J.A. Porco Jr., and J. Pelletier Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model J. Clin. Invest. 118 2008 2651 2660
17. V.V. Borutinskaite, K.E. Magnusson, and R. Navakauskiene α-Dystrobrevin distribution and association with other proteins in human promyelocytic NB4 cells treated for granulocytic differentiation Mol. Biol. Rep. 38 2011 3001 3011
18. I. Bourges, C. Ramus, B. Mousson de Camaret, R. Beugnot, C. Remacle, P. Cardol, G. Hofhaus, and J.P. Issartel Structural organization of mitochondrial human complex I: role of the ND4 and ND5 mitochondria-encoded subunits and interaction with prohibitin Biochem. J. 383 2004 491 499
19. E.W. Bush, and T.A. McKinsey Targeting histone deacetylases for heart failure Expert Opin. Ther. Targets 13 2009 767 784
20. 2+ channel TRPM6 by estrogen and the associated repressor protein of estrogen receptor activity (REA) J. Biol. Chem. 284 2009 14788 14795
21. R. Cencic, M. Carrier, G. Galicia-Vázquez, M.E. Bordeleau, R. Sukarieh, A. Bourdeau, B. Brem, J.G. Teodoro, H. Greger, and M.L. Tremblay Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol PLoS ONE 4 2009 e5223
22. H. Chander, M. Halpern, L. Resnick-Silverman, J.J. Manfredi, and D. Germain Skp2B attenuates p53 function by inhibiting prohibitin EMBO Rep. 11 2010 220 225
23. H. Chander, M. Halpern, L. Resnick-Silverman, J.J. Manfredi, and D. Germain Skp2B overexpression alters a prohibitin-p53 axis and the transcription of PAPP-A, the protease of insulin-like growth factor binding protein 4 PLoS ONE 6 2011 e22456
24. S.Y. Chang, S.J. Bae, M.Y. Lee, S.H. Baek, S. Chang, and S.H. Kim Chemical affinity matrix-based identification of prohibitin as a binding protein to anti-resorptive sulfonyl amidine compounds Bioorg. Med. Chem. Lett. 21 2011 727 729
25. Y.W. Chen, H.C. Chou, P.C. Lyu, H.S. Yin, F.L. Huang, W.S. Chang, C.Y. Fan, I.F. Tu, T.C. Lai, and S.T. Lin Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers Funct. Integr. Genomics 11 2011 225 239
26. R. Chhabra, R. Dubey, and N. Saini Cooperative and individualistic functions of the microRNAs in the miR-23a∼27a∼24-2 cluster and its implication in human diseases Mol. Cancer 9 2010 232
27. D. Choi, S.J. Lee, S. Hong, I.H. Kim, and S. Kang Prohibitin interacts with RNF2 and regulates E2F1 function via dual pathways Oncogene 27 2008 1716 1725
28. C.-F. Chiu, J.-M. Peng, S.-W. Hung, C.-M. Liang, and S.-M. Liang Recombinant viral capsid protein VP1 suppresses migration and invasion of human cervical cancer by modulating phosphorylated prohibitin in lipid rafts Cancer Lett. 320 2012 205 214
29. C.F. Chiu, M.Y. Ho, J.M. Peng, S.W. Hung, W.H. Lee, C.M. Liang, and S.M. Liang Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane Oncogene 32 2013 777 787
30. I. Chowdhury, W. Xu, J.K. Stiles, A. Zeleznik, X. Yao, R. Matthews, K. Thomas, and W.E. Thompson Apoptosis of rat granulosa cells after staurosporine and serum withdrawal is suppressed by adenovirus-directed overexpression of prohibitin Endocrinology 148 2007 206 217
31. I. Chowdhury, A. Branch, M. Olatinwo, K. Thomas, R. Matthews, and W.E. Thompson Prohibitin (PHB) acts as a potent survival factor against ceramide induced apoptosis in rat granulosa cells Life Sci. 89 2011 295 303
32. P.J. Coates, R. Nenutil, A. McGregor, S.M. Picksley, D.H. Crouch, P.A. Hall, and E.G. Wright Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence Exp. Cell Res. 265 2001 262 273
33. C.T. Cornillez-Ty, L. Liao, J.R. Yates 3rd, P. Kuhn, and M.J. Buchmeier Severe acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling J. Virol. 83 2009 10314 10318
34. C.S. Da, P.A. Parone, P. Gonzalo, W.V. Bienvenut, D. Tondera, A. Jourdain, M. Quadroni, and J.-C. Martinou SLP-2 interacts with prohibitins in the mitochondrial inner membrane and contributes to their stability Biochim. Biophys. Acta, Mol. 1783 2008 904 911
35. R. Delage-Mourroux, P.G. Martini, I. Choi, D.M. Kraichely, J. Hoeksema, and B.S. Katzenellenbogen Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA J. Biol. Chem. 275 2000 35848 35856
36. Q. Ding, S. Vaynman, P. Souda, J.P. Whitelegge, and F. Gomez-Pinilla Exercise affects energy metabolism and neural plasticity-related proteins in the hippocampus as revealed by proteomic analysis Eur. J. Neurosci. 24 2006 1265 1276
37. S.S. Ebada, N. Lajkiewicz, J.A. Porco Jr., M. Li-Weber, and P. Proksch Chemistry and biology of rocaglamides (= flavaglines) and related derivatives from aglaia species (meliaceae) Fortschr. Chem. Org. Naturst. 94 2011 1 58
38. V. Emerson, D. Holtkotte, T. Pfeiffer, I.H. Wang, M. Schnölzer, T. Kempf, and V. Bosch Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein J. Virol. 84 2010 1355 1365
39. H. Endo PHB2-PGC1alpha complex, adipogenesis controllers containing substance which controls formation of the complex or fragment or mutant of PHB2, PGC1alpha controllers containing fragment or mutant of PHB2, and screening of adipogenesis controllers Japanese Patent 2011 2011116753A
40. S. Erlich, A. Alexandrovich, E. Shohami, and R. Pinkas-Kramarski Rapamycin is a neuroprotective treatment for traumatic brain injury Neurobiol. Dis. 26 2007 86 93
41. T. Fahrig, I. Gerlach, and E. Horváth A synthetic derivative of the natural product rocaglaol is a potent inhibitor of cytokine-mediated signaling and shows neuroprotective activity in vitro and in animal models of Parkinson's disease and traumatic brain injury Mol. Pharmacol. 67 2005 1544 1555
42. C.E. Fletcher, D.A. Dart, A. Sita-Lumsden, H. Cheng, P.S. Rennie, and C.L. Bevan Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer Hum. Mol. Genet. 21 2012 3112 3127
43. G. Fusaro, P. Dasgupta, S. Rastogi, B. Joshi, and S. Chellappan Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling J. Biol. Chem. 278 2003 47853 47861
44. S.C. Gamble, D. Chotai, M. Odontiadis, D.A. Dart, G.N. Brooke, S.M. Powell, V. Reebye, A. Varela-Carver, Y. Kawano, J. Waxman, and C.L. Bevan Prohibitin, a protein downregulated by androgens, represses androgen receptor activity Oncogene 26 2007 1757 1768
45. J. Garin, R. Diez, S. Kieffer, J.F. Dermine, S. Duclos, E. Gagnon, R. Sadoul, C. Rondeau, and M. Desjardins The phagosome proteome: insight into phagosome functions J. Cell Biol. 152 2001 165 180
46. M. Gertz, F. Fischer, D. Wolters, and C. Steegborn Activation of the lifespan regulator p66Shc through reversible disulfide bond formation Proc. Natl. Acad. Sci. USA 105 2008 5705 5709
47. L. Gomez, M. Paillard, M. Price, Q. Chen, G. Teixeira, S. Spiegel, and E.J. Lesnefsky A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection Basic Res. Cardiol. 106 2011 1341 1353
48. S. Gratia, L. Kay, S. Michelland, M. Sève, U. Schlattner, and M. Tokarska-Schlattner Cardiac phosphoproteome reveals cell signaling events involved in doxorubicin cardiotoxicity J. Proteomics 75 2012 4705 4716
49. Y. Gu, S.R. Ande, and S. Mishra Altered O-GlcNAc modification and phosphorylation of mitochondrial proteins in myoblast cells exposed to high glucose Arch. Biochem. Biophys. 505 2011 98 104
50. S.V. Gupta, E.J. Sass, M.E. Davis, R.B. Edwards, G. Lozanski, N.A. Heerema, A. Lehman, X. Zhang, D. Jarjoura, and J.C. Byrd Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells AAPS J. 13 2011 357 364
51. M.E. Gutierrez, S. Kummar, and G. Giaccone Next generation oncology drug development: opportunities and challenges Nat. Rev. Clin. Oncol. 6 2009 259 265
52. B. Hausott, H. Greger, and B. Marian Flavaglines: a group of efficient growth inhibitors block cell cycle progression and induce apoptosis in colorectal cancer cells Int. J. Cancer 109 2004 933 940
53. B. He, Q. Feng, A. Mukherjee, D.M. Lonard, F.J. DeMayo, B.S. Katzenellenbogen, J.P. Lydon, and B.W. O'Malley A repressive role for prohibitin in estrogen signaling Mol. Endocrinol. 22 2008 344 360
54. J. He, H.M. Cooper, A. Reyes, M. Di Re, H. Sembongi, T.R. Litwin, J. Gao, K.C. Neuman, I.M. Fearnley, and A. Spinazzola Mitochondrial nucleoid interacting proteins support mitochondrial protein synthesis Nucleic Acids Res. 40 2012 6109 6121
55. J. Heidler, N. Al-Furoukh, C. Kukat, I. Salwig, M.-E. Ingelmann, P. Seibel, M. Krüger, J. Holtz, I. Wittig, T. Braun, and M. Szibor Nitric oxide-associated protein 1 (NOA1) is necessary for oxygen-dependent regulation of mitochondrial respiratory complexes J. Biol. Chem. 286 2011 32086 32093
56. P. Henschke, H. Vorum, B. Honoré, and G.E. Rice Protein profiling the effects of in vitro hyperoxic exposure on fetal rabbit lung Proteomics 6 2006 1957 1962
57. L. Héron-Milhavet, D. Mamaeva, A. Rochat, N.J.C. Lamb, and A. Fernandez Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA J. Cell. Physiol. 214 2008 158 165
58. S.-Y. Hsieh, T.-C. Shih, C.-Y. Yeh, C.-J. Lin, Y.-Y. Chou, and Y.-S. Lee Comparative proteomic studies on the pathogenesis of human ulcerative colitis Proteomics 6 2006 5322 5331
59. B.Y. Hwang, B.N. Su, H. Chai, Q. Mi, L.B. Kardono, J.J. Afriastini, S. Riswan, B.D. Santarsiero, A.D. Mesecar, and R. Wild Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris J. Org. Chem. 69 2004 3350 3358
60. C. Hwang, V.N. Giri, J.C. Wilkinson, C.W. Wright, A.S. Wilkinson, K.A. Cooney, and C.S. Duckett EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor Breast Cancer Res. Treat. 107 2008 235 242
61. R. Jain, A. Ghoshal, C. Mandal, and C. Shaha Leishmania cell surface prohibitin: role in host-parasite interaction Cell. Microbiol. 12 2010 432 452
62. K.-S. Jang, J.E. Baik, S.-S. Kang, J.H. Jeon, S. Choi, Y.-H. Yang, B.-G. Kim, C.-H. Yun, and S.H. Han Identification of staphylococcal lipoteichoic acid-binding proteins in human serum by high-resolution LTQ-Orbitrap mass spectrometry Mol. Immunol. 50 2012 177 183
63. D.P. Jones Radical-free biology of oxidative stress Am. J. Physiol. Cell Physiol. 295 2008 C849 C868
64. B. Joshi, D. Ko, D. Ordonez-Ercan, and S.P. Chellappan A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis Biochem. Biophys. Res. Commun. 312 2003 459 466
65. B. Joshi, S. Rastogi, M. Morris, L.M. Carastro, C. DeCook, E. Seto, and S.P. Chellappan Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites Biochem. J. 401 2007 155 166
66. K. Kasashima, E. Ohta, Y. Kagawa, and H. Endo Mitochondrial functions and estrogen receptor-dependent nuclear translocation of pleiotropic human prohibitin 2 J. Biol. Chem. 281 2006 36401 36410
67. K. Kasashima, M. Sumitani, M. Satoh, and H. Endo Human prohibitin 1 maintains the organization and stability of the mitochondrial nucleoids Exp. Cell Res. 314 2008 988 996
68. L.S. Kategaya, A. Hilliard, L. Zhang, J.M. Asara, L.J. Ptáček, and Y.-H. Fu Casein kinase 1 proteomics reveal prohibitin 2 function in molecular clock PLoS ONE 7 2012 e31987
69. A.S. Kathiria, L.D. Butcher, L.A. Feagins, R.F. Souza, C.R. Boland, and A.L. Theiss Prohibitin 1 modulates mitochondrial stress-related autophagy in human colonic epithelial cells PLoS ONE 7 2012 e31231
70. A.S. Kathiria, W.L. Neumann, J. Rhees, E. Hotchkiss, Y. Cheng, R.M. Genta, S.J. Meltzer, R.F. Souza, and A.L. Theiss Prohibitin attenuates colitis-associated tumorigenesis in mice by modulating p53 and STAT3 apoptotic responses Cancer Res. 72 2012 5778 5789
71. S. Khan, F. Salloum, A. Das, L. Xi, G.W. Vetrovec, and R.C. Kukreja Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes J. Mol. Cell. Cardiol. 41 2006 256 264
72. N. Kim, Y. Lee, H. Kim, H. Joo, J.B. Youm, W.S. Park, M. Warda, D.V. Cuong, and J. Han Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics Proteomics 6 2006 1237 1249
73. S. Kim, B.Y. Hwang, B.N. Su, H. Chai, Q. Mi, A.D. Kinghorn, R. Wild, and S.M. Swanson Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/ apoptosome pathway without activation of executioner caspase-3 or -7 Anticancer Res. 27 2007 2175 2183
74. J.-W. Kim, M. Akiyama, J.-H. Park, M.-L. Lin, A. Shimo, T. Ueki, Y. Daigo, T. Tsunoda, T. Nishidate, Y. Nakamura, and T. Katagiri Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer Cancer Sci. 100 2009 1468 1478
75. D.H. Kim, S.C. Woods, and R.J. Seeley Peptide designed to elicit apoptosis in adipose tissue endothelium reduces food intake and body weight Diabetes 59 2010 907 915
76. M.L. King, C.C. Chiang, H.C. Ling, E. Fujita, M. Ochiai, and A.T. McPhail X-Ray crystal structure of rocaglamide, a novel antileukemic 1H-cyclopenta[b]benzofuran from Aglaia elliptifolia J. Chem. Soc., Chem. Commun. 20 1982 1150 1151
77. M.G. Kolonin, P.K. Saha, L. Chan, R. Pasqualini, and W. Arap Reversal of obesity by targeted ablation of adipose tissue Nat. Med. 10 2004 625 632
78. S. Kostenko, and U. Moens Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology Cell. Mol. Life Sci. 66 2009 3289 3307
79. A. Kuadkitkan, N. Wikan, C. Fongsaran, and D.R. Smith Identification and characterization of prohibitin as a receptor protein mediating DENV-2 entry into insect cells Virology 406 2010 149 161
80. V. Kurtev, R. Margueron, K. Kroboth, E. Ogris, V. Cavailles, and C. Seiser Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases J. Biol. Chem. 279 2004 24834 24843
81. S.K. Lee, B. Cui, R.R. Mehta, A.D. Kinghorn, and J.M. Pezzuto Cytostatic mechanism and antitumor potential of novel 1H-cyclopenta[b]benzofuran lignans isolated from Aglaia elliptica Chem. Biol. Interact. 115 1998 215 228
82. S.J. Lee, D. Choi, H. Rhim, H.J. Choo, Y.G. Ko, C.G. Kim, and S. Kang PHB2 interacts with RNF2 and represses CP2c-stimulated transcription Mol. Cell. Biochem. 319 2008 69 77
83. H. Lee, H. Arnouk, S. Sripathi, P. Chen, R. Zhang, M. Bartoli, R.C. Hunt, W.J.M. Hrushesky, H. Chung, S.H. Lee, and W.J. Jahng Prohibitin as an oxidative stress biomarker in the eye Int. J. Biol. Macromol. 47 2010 685 690
84. J.H. Lee, K.H. Nguyen, S. Mishra, and B.L.G. Nyomba Prohibitin is expressed in pancreatic β-cells and protects against oxidative and proapoptotic effects of ethanol FEBS J. 277 2010 488 500
85. M.Y. Lee, M.H. Kim, J. Kim, S.H. Kim, B.T. Kim, I.H. Jeong, S. Chang, S.H. Kim, and S.Y. Chang Synthesis and SAR of sulfonyl- and phosphoryl amidine compounds as anti-resorptive agents Bioorg. Med. Chem. Lett. 20 2010 541 545
86. Q.-F. Li, Y. Liang, S.-L. Shi, Q.-R. Liu, D.-H. Xu, G.-J. Jing, S.-Y. Wang, and H.-Y. Kong Localization of prohibitin in the nuclear matrix and alteration of its expression during differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid Cell. Mol. Neurobiol. 31 2011 203 211
87. L. Lih-Brody, S.R. Powell, K.P. Collier, G.M. Reddy, R. Cerchia, E. Kahn, G.S. Weissman, S. Katz, R.A. Floyd, and M.J. McKinley Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease Dig. Dis. Sci. 41 1996 2078 2086
88. X.H. Liu, L.J. Qian, J.B. Gong, J. Shen, X.M. Zhang, and X.H. Qian Proteomic analysis of mitochondrial proteins in cardiomyocytes from chronic stressed rat Proteomics 4 2004 3167 3176
89. T. Liu, H. Tang, Y. Lang, M. Liu, and X. Li MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin Cancer Lett. 273 2009 233 242
90. X. Liu, Z. Ren, R. Zhan, X. Wang, X. Wang, Z. Zhang, X. Leng, Z. Yang, and L. Qian Prohibitin protects against oxidative stress-induced cell injury in cultured neonatal cardiomyocyte Cell Stress Chaperones 14 2009 311 319
91. X.H. Liu, Z.Q. Zhang, R. Zhan, X.X. Wang, L.Q. Wang, X. Leng, X.J. Gao, and L.J. Qian Identification of interaction between HSP70 and prohibitin by co-immunoprecipitation Jiefangjun Yufang Yixue Zazhi 28 2010 316 319
92. T. Liu, S.J. Nair, A. Lescarbeau, J. Belani, S. Peluso, J. Conley, B. Tillotson, P. O'Hearn, S. Smith, and K. Slocum Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors J. Med. Chem. 55 2012 8859 8878
93. D.M. Lucas, R.B. Edwards, G. Lozanski, D.A. West, J.D. Shin, M.A. Vargo, M.E. Davis, D.M. Rozewski, A.J. Johnson, and B.N. Su The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo Blood 113 2009 4656 4666
94. C.R. Lucas, H.M. Cordero-Nieves, R.S. Erbe, J.W. McAlees, S. Bhatia, R.J. Hodes, K.S. Campbell, and V.M. Sanders Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes J. Immunol. 190 2013 723 736
95. Madireddi, M. (June 2006). Protein-protein interactions of p66.sup.ShcA. U.S. Patent 7,056,684.
96. A. Mai, D. Rotili, S. Valente, and A.G. Kazantsev Histone deacetylase inhibitors and neurodegenerative disorders: holding the promise Curr. Pharm. Des. 15 2009 3940 3957
97. C. Malagelada, Z.H. Jin, V. Jackson-Lewis, S. Przedborski, and L.A. Greene Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease J. Neurosci. 30 2010 1166 1175
98. S. Manjeshwar, D.E. Branam, M.R. Lerner, D.J. Brackett, and E.R. Jupe Tumor suppression by the prohibitin gene 3'untranslated region RNA in human breast cancer Cancer Res. 63 2003 5251 5256
99. B. Martín, R. Sanz, R. Aragüés, B. Oliva, and A. Sierra Functional clustering of metastasis proteins describes plastic adaptation resources of breast-cancer cells to new microenvironments J. Proteome Res. 7 2008 3242 3253
100. D. Matallanas, M. Birtwistle, D. Romano, A. Zebisch, J. Rauch, A. von Kriegsheim, and W. Kolch Raf family kinases: old dogs have learned new tricks Genes Cancer 2 2011 232 260
101. G. Maurer, B. Tarkowski, and M. Baccarini Raf kinases in cancer-roles and therapeutic opportunities Oncogene 30 2011 3477 3488
102. J.K. McClung, D.B. Danner, D.A. Stewart, J.R. Smith, E.L. Schneider, C.K. Lumpkin, R.T. Dell'Orco, and M.J. Nuell Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver Biochem. Biophys. Res. Commun. 164 1989 1316 1322
103. J. Mengwasser, A. Piau, P. Schlag, and J.P. Sleeman Differential immunization identifies PHB1/PHB2 as blood-borne tumor antigens Oncogene 23 2004 7430 7435
104. C. Merkwirth, S. Dargazanli, T. Tatsuta, S. Geimer, B. Löwer, F.T. Wunderlich, J.C. von Kleist-Retzow, A. Waisman, B. Westermann, and T. Langer Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria Genes Dev. 22 2008 476 488
105. C. Merkwirth, P. Martinelli, A. Korwitz, M. Morbin, H.S. Brönneke, S.D. Jordan, E.I. Rugarli, and T. Langer Loss of prohibitin membrane scaffolds impairs mitochondrial architecture and leads to tau hyperphosphorylation and neurodegeneration PLoS Genet. 8 2012 e1003021
106. B.M. Meurer-Grimes, J. Yu, and G.L. Vairo Therapeutic compounds and methods Australian Patent AU2001268848 November 2002
107. Q. Mi, S. Kim, B.Y. Hwang, B.N. Su, H. Chai, Z.H. Arbieva, A.D. Kinghorn, and S.M. Swanson Silvestrol regulates G2/M checkpoint genes independent of p53 activity Anticancer Res. 26 5A 2006 3349 3356
108. Q. Mi, B.N. Su, H. Chai, G.A. Cordell, N.R. Farnsworth, A.D. Kinghorn, and S.M. Swanson Rocaglaol induces apoptosis and cell cycle arrest in LNCaP cells Anticancer Res. 26 2A 2006 947 952
109. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity Pharmacol. Rev. 56 2004 185 229
110. S. Mishra, S. Moulik, and L.J. Murphy Prohibitin binds to C3 and enhances complement activation Mol. Immunol. 44 2007 1897 1902
111. S. Mishra, S.R. Ande, and B.L.G. Nyomba The role of prohibitin in cell signaling FEBS J. 277 2010 3937 3946
112. M.M. Montano, K. Ekena, R. Delage-Mourroux, W. Chang, P. Martini, and B.S. Katzenellenbogen An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens Proc. Natl. Acad. Sci. USA 96 1999 6947 6952
113. T. Muraguchi, A. Kawawa, and S. Kubota Prohibitin protects against hypoxia-induced H9c2 cardiomyocyte cell death Biomed. Res. 31 2010 113 122
114. Z. Nasr, F. Robert, J.A. Porco Jr., W.J. Muller, and J. Pelletier eIF4F suppression in breast cancer affects maintenance and progression Oncogene 32 2013 861 871
115. L.G.J. Nijtmans, L. de Jong, M. Artal Sanz, P.J. Coates, J.A. Berden, J.W. Back, A.O. Muijsers, H. van der Spek, and L.A. Grivell Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins EMBO J. 19 2000 2444 2451
116. L.G.J. Nijtmans, S.M. Artal, L.A. Grivell, and P.J. Coates The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease Cell. Mol. Life Sci. 59 2002 143 155
117. M.J. Nuell, D.A. Stewart, L. Walker, V. Friedman, C.M. Wood, G.A. Owens, J.R. Smith, E.L. Schneider, R. Dell' Orco, and C.K. Lumpkin Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells Mol. Cell. Biol. 11 1991 1372 1381
118. S. Oeljeklaus, B.S. Reinartz, J. Wolf, S. Wiese, J. Tonillo, K. Podwojski, K. Kuhlmann, C. Stephan, H.E. Meyer, and W. Schliebs Identification of core components and transient interactors of the peroxisomal importomer by dual-track stable isotope labeling with amino acids in cell culture analysis J. Proteome Res. 11 2012 2567 2580
119. T. Ohse, S. Ohba, T. Yamamoto, T. Koyano, and K. Umezawa Cyclopentabenzofuran lignan protein synthesis inhibitors from Aglaia odorata J. Nat. Prod. 59 1996 650 652
120. L.L. Paris, J.-J. Hu, J. Galan, S.-S. Ong, V.A. Martin, H.-Y. Ma, W.A. Tao, M.L. Harrison, and R.L. Geahlen Regulation of Syk by phosphorylation on serine in the linker insert J. Biol. Chem. 285 2010 39844 39854
121. B. Park, J. Yang, N. Yun, K.-M. Choe, B.K. Jin, and Y.J. Oh Proteomic analysis of expression and protein interactions in a 6-hydroxydopamine-induced rat brain lesion model Neurochem. Int. 57 2010 16 32
122. N. Patel, S.K. Chatterjee, V. Vrbanac, I. Chung, C.J. Mu, R.R. Olsen, C. Waghorne, and B.R. Zetter Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells Proc. Natl. Acad. Sci. USA 107 2010 2503 2508
123. C. Picard, M. Pellicelli, M. Taheri, J.F. Lavoie, R. Doucet, D. Wang, L. Bernard, S. Bouhanik, P. Lavigne, and A. Moreau Nuclear accumulation of PHB1 in osteoarthritic chondrocytes downregulates PITX1 expression levels Arthritis Rheum. 2013 10.1002/art.37837 in press
124. G. Polier, J. Neumann, F. Thuaud, N. Ribeiro, C. Gelhaus, H. Schmidt, M. Giaisi, R. Köhler, W.W. Müller, and P. Proksch The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2 Chem. Biol. 19 2012 1093 1104
125. P. Proksch, M. Giaisi, M.K. Treiber, K. Palfi, A. Merling, H. Spring, P.H. Krammer, and M. Li-Weber Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells J. Immunol. 174 2005 7075 7084
126. K. Rajalingam, C. Wunder, V. Brinkmann, Y. Churin, M. Hekman, C. Sievers, U.R. Rapp, and T. Rudel Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration Nat. Cell Biol. 7 2005 837 843
127. R.K. Rasmussen, H. Ji, J.S. Eddes, R.L. Moritz, G.E. Reid, R.J. Simpson, and D.S. Dorow Two-dimensional electrophoretic analysis of mixed lineage kinase 2 N-terminal domain binding proteins Electrophoresis 19 1998 809 817
128. S. Rastogi, B. Joshi, P. Dasgupta, M. Morris, K. Wright, and S. Chellappan Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes Mol. Cell. Biol. 26 2006 4161 4171
129. S. Rastogi, B. Joshi, G. Fusaro, and S. Chellappan Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanism J. Biol. Chem. 281 2006 2951 2959
130. N. Ribeiro, F. Thuaud, Y. Bernard, C. Gaiddon, T. Cresteil, A. Hild, E.C. Hirsch, P.P. Michel, C.G. Nebigil, and L. Désaubry Flavaglines as potent anticancer and cytoprotective agents J. Med. Chem. 55 2012 10064 10073
131. N. Ribeiro, F. Thuaud, C. Nebigil, and L. Désaubry Recent advances in the biology and chemistry of the flavaglines Bioorg. Med. Chem. 20 2012 1857 1864
132. W. Rizwani, M. Alexandrow, and S. Chellappan Prohibitin physically interacts with MCM proteins and inhibits mammalian DNA replication Cell Cycle 8 2009 1621 1629
133. F. Robert, M. Carrier, S. Rawe, S. Chen, S. Lowe, and J. Pelletier Altering chemosensitivity by modulating translation elongation PLoS ONE 4 2009 e5428
134. J.A. Ross, Z.S. Nagy, and R.A. Kirken The PHB1/2 phosphocomplex is required for mitochondrial homeostasis and survival of human T cells J. Biol. Chem. 283 2008 4699 4713
135. V. Sánchez-Quiles, V. Segura, E. Bigaud, B. He, B.W. O'Malley, E. Santamaría, J. Prieto, and F.J. Corrales Prohibitin-1 deficiency promotes inflammation and increases sensitivity to liver injury J. Proteomics 75 2012 5783 5792
136. S.-I. Sato, A. Murata, T. Orihara, T. Shirakawa, K. Suenaga, H. Kigoshi, and M. Uesugi Marine natural product aurilide activates the OPA1-mediated apoptosis by binding to prohibitin Chem. Biol. 18 2011 131 139
137. J.H. Schatz, E. Oricchio, A.L. Wolfe, M. Jiang, I. Linkov, J. Maragulia, W. Shi, Z. Zhang, V.K. Rajasekhar, and N.C. Pagano Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma J. Exp. Med. 208 2011 1799 1807
138. A. Sharma, and A. Qadri Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses Proc. Natl. Acad. Sci. USA 101 2004 17492 17497
139. M. Schneider, A. Schambony, and D. Wedlich Prohibitin1 acts as a neural crest specifier in Xenopus development by repressing the transcription factor E2F1 Development 137 2010 4073 4081
140. J.R. Snyder, A. Hall, L. Ni-Komatsu, S.M. Khersonsky, Y.T. Chang, and S.J. Orlow Dissection of melanogenesis with small molecules identifies prohibitin as a regulator Chem. Biol. 12 2005 477 484
141. S.R. Sripathi, W. He, C.L. Atkinson, J.J. Smith, Z. Liu, B.M. Elledge, and W.J. Jahng Mitochondrial-nuclear communication by prohibitin shuttling under oxidative stress Biochemistry 50 2011 8342 8351
142. F.I. Staquicini, M. Cardó-Vila, M.G. Kolonin, M. Trepel, J.K. Edwards, D.N. Nunes, A. Sergeeva, E. Efstathiou, J. Sun, and N.F. Almeida Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients Proc. Natl. Acad. Sci. USA 108 2011 18637 18642
143. G. Steglich, W. Neupert, and T. Langer Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria Mol. Cell. Biol. 19 1999 3435 3442
144. G.M. Strub, M. Paillard, J. Liang, L. Gomez, J.C. Allegood, N.C. Hait, M. Maceyka, M.M. Price, Q. Chen, and D.C. Simpson Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration FASEB J. 25 2011 600 612
145. B.N. Su, H. Chai, Q. Mi, S. Riswan, L.B. Kardono, J.J. Afriastini, B.D. Santarsiero, A.D. Mesecar, N.R. Farnsworth, and G.A. Cordell Activity-guided isolation of cytotoxic constituents from the bark of Aglaia crassinervia collected in Indonesia Bioorg. Med. Chem. 14 2006 960 972
146. K. Suenaga, T. Mutou, T. Shibata, T. Itoh, H. Kigoshi, and K. Yamada Isolation and stereostructure of aurilide, a novel cyclodepsipeptide from the Japanese sea hare Dolabella auricularia Tetrahedron Lett. 37 1996 6771 6774
147. K. Suenaga, T. Mutou, T. Shibata, T. Itoh, T. Fujita, N. Takada, K. Hayamizu, M. Takagi, T. Irifune, H. Kigoshi, and K. Yamada Aurilide, a cytotoxic depsipeptide from the sea hare Dolabella auricularia: Isolation, structure determination, synthesis, and biological activity Tetrahedron 60 2004 8509 8527
148. L. Sun, L. Liu, X.-J. Yang, and Z. Wu Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation J. Cell Sci. 117 2004 3021 3029
149. L. Sun, X. Cao, B. Liu, H. Huang, X. Wang, L. Sui, W. Yin, and K. Ma CaMK
150. T. Tatsuta, K. Model, and T. Langer Formation of membrane-bound ring complexes by prohibitins in mitochondria Mol. Biol. Cell 16 2005 248 259
151. M. Terashima, K.-M. Kim, T. Adachi, P.J. Nielsen, M. Reth, G. Köhler, and M.C. Lamers The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein EMBO J. 13 1994 3782 3792
152. A.L. Theiss, R.D. Idell, S. Srinivasan, J.M. Klapproth, D.P. Jones, D. Merlin, and S.V. Sitaraman Prohibitin protects against oxidative stress in intestinal epithelial cells FASEB J. 21 2007 197 206
153. A.L. Theiss, T.S. Obertone, D. Merlin, and S.V. Sitaraman Interleukin-6 transcriptionally regulates prohibitin expression in intestinal epithelial cells J. Biol. Chem. 282 2007 12804 12812
154. A.L. Theiss, A.K. Jenkins, N.I. Okoro, J.M. Klapproth, D. Merlin, and S.V. Sitaraman Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expression Mol. Biol. Cell 20 2009 4412 4423
155. A.L. Theiss, M. Vijay-Kumar, T.S. Obertone, D.P. Jones, J.M. Hansen, A.T. Gewirtz, D. Merlin, and S.V. Sitaraman Prohibitin is a novel regulator of antioxidant response that attenuates colonic inflammation in mice Gastroenterology 137 2009 199 208
156. A.L. Theiss, H. Laroui, T.S. Obertone, I. Chowdhury, W.E. Thompson, D. Merlin, and S.V. Sitaraman Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis Inflamm. Bowel Dis. 17 2011 1163 1176
157. F. Thuaud, Y. Bernard, G. Türkeri, R. Dirr, G. Aubert, T. Cresteil, A. Baguet, C. Tomasetto, Y. Svitkin, and N. Sonenberg Synthetic analogue of rocaglaol displays a potent and selective cytotoxicity in cancer cells: involvement of apoptosis inducing factor and caspase-12 J. Med. Chem. 52 2009 5176 5187
158. F. Thuaud, N. Ribeiro, C. Gaiddon, T. Cresteil, and L. Désaubry Novel flavaglines displaying improved cytotoxicity J. Med. Chem. 54 2011 411 415
159. A. Trzeciakiewicz, S. Fortin, E. Moreau, R. C-Gaudreault, J. Lacroix, C. Chambon, Y. Communal, J.M. Chezal, E. Miot-Noirault, B. Bouchon, and F. Degoul Intramolecular cyclization of N-phenyl N'(2-chloroethyl)ureas leads to active N-phenyl-4,5-dihydrooxazol-2-amines alkylating β-tubulin Glu198 and prohibitin Asp40 Biochem. Pharmacol. 81 2011 1116 1123
160. T. Tsutsumi, M. Matsuda, H. Aizaki, K. Moriya, H. Miyoshi, H. Fujie, Y. Shintani, H. Yotsuyanagi, T. Miyamura, T. Suzuki, and K. Koike Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon, prohibitin, in cells expressing hepatitis C virus core protein Hepatology 50 2009 378 386
161. K. Umanskaya, S. Radke, H. Chander, R. Monardo, X. Xu, Z.-Q. Pan, M.J. O'Connell, and D. Germain Skp2B stimulates mammary gland development by inhibiting REA, the repressor of the estrogen receptor Mol. Cell. Biol. 27 2007 7615 7622
162. M. Vessal, S. Mishra, S. Moulik, and L.J. Murphy Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carboxylase FEBS J. 273 2006 568 576
163. S. Wang, N. Nath, M. Adlam, and S. Chellappan Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function Oncogene 18 1999 3501 3510
164. S. Wang, N. Nath, G. Fusaro, and S. Chellappan Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals Mol. Cell. Biol. 19 1999 7447 7460
165. S. Wang, B. Zhang, and D.V. Faller Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth EMBO J. 21 2002 3019 3028
166. P. Wintachai, N. Wikan, A. Kuadkitkan, T. Jaimipuk, S. Ubol, R. Pulmanausahakul, P. Auewarakul, W. Kasinrerk, W.Y. Weng, and M. Panyasrivanit Identification of prohibitin as a Chikungunya virus receptor protein J. Med. Virol. 84 2012 1757 1770
167. A. Winter, O. Kamarainen, and A. Hofmann Molecular modeling of prohibitin domains Proteins 68 2007 353 362
168. Q. Wu, and S. Wu Lipid rafts association and anti-apoptotic function of prohibitin in ultraviolet B light-irradiated HaCaT keratinocytes Exp. Dermatol. 21 2012 640 642
169. M. Yeo, D.K. Kim, H.J. Park, T.Y. Oh, J.H. Kim, S.W. Cho, Y.K. Paik, and K.B. Hahm Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis Proteomics 6 2006 1158 1165
170. H. Yurugi, S. Tanida, A. Ishida, K. Akita, M. Toda, M. Inoue, and H. Nakada Expression of prohibitins on the surface of activated T cells Biochem. Biophys. Res. Commun. 420 2012 275 280
171. Y. Zhang, Y. Wang, Y. Xiang, W. Lee, and Y. Zhang Prohibitins are involved in protease-activated receptor 1-mediated platelet aggregation J. Thromb. Haemost. 10 2012 411 418
172. P. Zhou, L. Qian, M. D'Aurelio, S. Cho, G. Wang, G. Manfredi, V. Pickel, and C. Iadecola Prohibitin reduces mitochondrial free radical production and protects brain cells from different injury modalities J. Neurosci. 32 2012 583 592
173. J.Y. Zhu, I.N. Lavrik, U. Mahlknecht, M. Giaisi, P. Proksch, P.H. Krammer, and M. Li-Weber The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities Int. J. Cancer 121 2007 1839 1846
174. J.Y. Zhu, M. Giaisi, R. Köhler, W.W. Müller, A. Mühleisen, P. Proksch, P.H. Krammer, and M. Li-Weber Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression Cell Death Differ. 16 2009 1289 1299
175. B. Zhu, J. Zhai, H. Zhu, and N. Kyprianou Prohibitin regulates TGF-β induced apoptosis as a downstream effector of Smad-dependent and -independent signaling Prostate 70 2010 17 26